SCHEMBL26699403

SCHEMBL26699403

CCCCCCCCC(C)CCCCCCCCCCCCC(=O)OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.56
ACE2 Q9BYF1 1/20 0.55
MAPT P10636 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
PPARG P37231 2/20 0.51
PPARA Q07869 1/20 0.51
POLB P06746 1/20 0.50
POLA1 P09884 1/20 0.50
DGKA P23743 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 2/20 0.49
ZDHHC7 Q9NXF8 1/20 0.49
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
MEN1 O00255 1/20 0.47
FAAH O00519 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26699386 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL30801422 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL26699392 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL15305641 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL19289180 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL30801435 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL17364263 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL333041 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL19995790 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG
SCHEMBL26699397 1.00 LMNA (0.56) LMNAACE2MAPTL3MBTL1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230346951-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS YALE UNIVERSITY 2023-11-02 US disclosed
US-20230346951-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS YALE UNIVERSITY 2023-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230346951-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS ASGR1, MSR1, LDLR LMNA 2180/4885ACE2 1219/4885MAPT 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.